Hologic (HOLX) Lifted to Sell at BidaskClub

BidaskClub upgraded shares of Hologic (NASDAQ:HOLX) from a strong sell rating to a sell rating in a report released on Wednesday.

A number of other analysts also recently commented on the stock. Goldman Sachs set a $43.00 price objective on shares of Hologic and gave the company a buy rating in a report on Tuesday. Zacks Investment Research downgraded shares of Hologic from a buy rating to a hold rating in a report on Tuesday, March 6th. Canaccord Genuity restated a buy rating and set a $48.00 price target on shares of Hologic in a report on Friday, February 9th. Royal Bank of Canada restated a hold rating and set a $44.00 price target on shares of Hologic in a report on Friday, February 9th. Finally, Needham & Company LLC restated a buy rating and set a $50.00 price target on shares of Hologic in a report on Friday, February 9th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and nine have issued a buy rating to the company’s stock. The company currently has a consensus rating of Buy and an average target price of $47.21.

HOLX stock opened at $38.30 on Wednesday. The stock has a market capitalization of $10,676.79, a price-to-earnings ratio of 18.87, a price-to-earnings-growth ratio of 1.74 and a beta of 0.85. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.25 and a quick ratio of 0.98. Hologic has a 12 month low of $35.33 and a 12 month high of $46.80.

Hologic (NASDAQ:HOLX) last released its quarterly earnings data on Thursday, February 8th. The medical equipment provider reported $0.55 EPS for the quarter, beating the Zacks’ consensus estimate of $0.50 by $0.05. The company had revenue of $791.10 million during the quarter, compared to the consensus estimate of $785.80 million. Hologic had a net margin of 34.53% and a return on equity of 20.07%. Hologic’s quarterly revenue was up 7.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.52 EPS. sell-side analysts expect that Hologic will post 2.25 earnings per share for the current year.

In related news, SVP Allison P. Bebo sold 7,000 shares of Hologic stock in a transaction that occurred on Friday, March 16th. The shares were sold at an average price of $38.75, for a total value of $271,250.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Namal Nawana bought 6,600 shares of the company’s stock in a transaction that occurred on Tuesday, February 13th. The stock was bought at an average price of $37.88 per share, with a total value of $250,008.00. Following the acquisition, the director now directly owns 6,954 shares in the company, valued at approximately $263,417.52. The disclosure for this purchase can be found here. 0.79% of the stock is owned by company insiders.

A number of institutional investors have recently bought and sold shares of the stock. Creative Planning increased its holdings in Hologic by 8.2% in the 4th quarter. Creative Planning now owns 15,396 shares of the medical equipment provider’s stock valued at $658,000 after purchasing an additional 1,161 shares during the last quarter. AT Bancorp increased its holdings in Hologic by 2.2% in the 4th quarter. AT Bancorp now owns 62,329 shares of the medical equipment provider’s stock valued at $2,664,000 after purchasing an additional 1,323 shares during the last quarter. Flinton Capital Management LLC increased its holdings in Hologic by 9.2% in the 4th quarter. Flinton Capital Management LLC now owns 18,904 shares of the medical equipment provider’s stock valued at $808,000 after purchasing an additional 1,598 shares during the last quarter. Greenleaf Trust increased its holdings in Hologic by 1.5% in the 4th quarter. Greenleaf Trust now owns 112,101 shares of the medical equipment provider’s stock valued at $4,792,000 after purchasing an additional 1,675 shares during the last quarter. Finally, Public Employees Retirement Association of Colorado increased its holdings in Hologic by 0.5% in the 4th quarter. Public Employees Retirement Association of Colorado now owns 368,144 shares of the medical equipment provider’s stock valued at $15,738,000 after purchasing an additional 1,776 shares during the last quarter. Hedge funds and other institutional investors own 97.51% of the company’s stock.

WARNING: This article was first published by WKRB News and is the property of of WKRB News. If you are accessing this article on another website, it was illegally copied and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be viewed at https://www.wkrb13.com/2018/04/21/hologic-holx-lifted-to-sell-at-bidaskclub.html.

About Hologic

Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays.

Analyst Recommendations for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply